Get alerts for new trials in your area by subscribing now
Lupus is an autoimmune disease in which the immune system attacks the body's own tissues. Systemic lupus erythematosus, or SLE, the most common type, can affect the skin, joints, kidneys, blood, heart, lungs, and brain, and typically comes in flares of fatigue, joint pain, rashes, and fever. Women of childbearing age are at highest risk, and Black and American Indian or Alaska Native women are two to three times more likely than White women to develop it. Cutaneous lupus affects mainly the skin, and kidney involvement is covered on our lupus nephritis page. Treatment starts with hydroxychloroquine and adds steroids, immune suppressants, and biologics as needed; belimumab, approved in 2011, was the first new lupus drug in more than 50 years.
Lupus overlaps with other autoimmune disorders such as scleroderma and rheumatoid arthritis. Cell therapy is explained on our CAR T cell therapy page.
Cell therapy trials. CAR T cells that remove the B cells driving lupus, tested in people whose disease has not responded to standard treatment.
Biologic trials. Antibodies targeting B cells, interferon, and other immune pathways.
Oral drug trials. New pills, including Phase 3 studies for cutaneous lupus.
Pediatric trials. Studies in children and teenagers, who often have more severe disease.
Kidney involvement. Lupus nephritis trials, on their own page.
Most trials enroll adults with SLE meeting standard classification criteria and active disease on a set score despite standard treatment; CAR T trials require disease that has not responded to several treatments. Cutaneous lupus trials enroll people with active skin disease. Pediatric trials enroll children from about age 5. Many require a stable dose of current medicines. Eligibility always varies by study.
Systemic lupus erythematosus. Affects multiple organs; the main target of drug and cell therapy trials.
Cutaneous lupus. Mainly skin; has its own Phase 3 trials.
Lupus nephritis. Kidney involvement; separate trials on its own page.
Childhood onset lupus. Often more severe; studied in pediatric trials.
Identify your trial. Use the filters and match the stage or type and the treatment history named in study titles to your own.
Select your preferred location. Enter your city or state; large trials run at many sites, early phase studies at fewer centers.
Explore study details. Click "Learn More" for eligibility, prior treatment rules, and the visit schedule.
Complete the health profile. Click "Get started" to begin the 5-step application. Have three things ready: your lupus type and which organs are affected, your current medicines and doses, and recent flare history.
Submit the application. A clinical trial coordinator reviews it and contacts you. Nothing is decided until informed consent, and participation is voluntary at every step.